Largest pharmaceutical companies in the United States by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 44 pharmaceutical companies in the United States ranked by earnings, at NOK 261.4B, ahead of Eli Lilly (NOK 201.3B) and Merck & Co (NOK 178B). Figures as of 20 Nov 2026, 13:40 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- Johnson & JohnsonNOK 261.4B
- Median
- -NOK 465.8M
- Combined market value
- NOK 36.43T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | NOK 261.4B | NOK 6.27T | NOK 2,604.78 | 2.04% down | 31% up | ||
| 2 | Eli LillyLLY · Health Care | NOK 201.3B | NOK 11.73T | NOK 13,174.26 | 2.29% down | 28% up | ||
| 3 | Merck & CoMRK · Health Care | NOK 178B | NOK 3.19T | NOK 1,294.98 | 3.61% down | 36% up | ||
| 4 | PfizerPFE · Health Care | NOK 75.8B | NOK 1.53T | NOK 268.53 | 1.85% down | 10% up | ||
| 5 | Bristol-Myers SquibbBMY · Health Care | NOK 68.8B | NOK 1.16T | NOK 568.85 | 2.05% down | 26% up | ||
| 6 | Abbott LaboratoriesABT · Health Care | NOK 63.6B | NOK 1.75T | NOK 1,012.80 | 0.58% down | 19% down | ||
| 7 | Regeneron PharmaceuticalsREGN · Health Care | NOK 43.9B | NOK 931.4B | NOK 9,003.14 | 2.35% down | 22% up | ||
| 8 | AbbVieABBV · Health Care | NOK 41.2B | NOK 4.89T | NOK 2,764.69 | 0.86% down | 20% up | ||
| 9 | Vertex PharmaceuticalsVRTX · Health Care | NOK 38.5B | NOK 1.29T | NOK 5,076.76 | 2.94% down | 22% up | ||
| 10 | ZoetisZTS · Health Care | NOK 26.1B | NOK 320.1B | NOK 787.75 | 5.59% down | 34% down | ||
| 11 | United TherapeuticsUTHR · Health Care | NOK 13B | NOK 232.2B | NOK 5,451.57 | 3.16% down | 18% up | ||
| 12 | Royalty PharmaRPRX · Health Care | NOK 7.5B | NOK 379.7B | NOK 660.31 | 1.38% down | 74% up | ||
| 13 | PTC TherapeuticsPTCT · Health Care | NOK 6.7B | NOK 47.5B | NOK 568.70 | 3.16% down | 26% down | ||
| 14 | TG TherapeuticsTGTX · Health Care | NOK 4.4B | NOK 95.6B | NOK 632.62 | 1.88% down | 103% up | ||
| 15 | BioMarin PharmaceuticalBMRN · Health Care | NOK 3.4B | NOK 116B | NOK 598.88 | 0.02% down | 12% up | ||
| 16 | Alnylam PharmaceuticalsALNY · Health Care | NOK 3.1B | NOK 193B | NOK 1,441.34 | 1.06% down | 66% down | ||
| 17 | Ligand PharmaceuticalsLGND · Health Care | NOK 1.2B | NOK 56B | NOK 2,797.84 | 3.94% down | 44% up | ||
| 18 | Corcept TherapeuticsCORT · Health Care | NOK 971.7M | NOK 69.3B | NOK 633.60 | 4.15% down | 16% down | ||
| 19 | Amneal PharmaceuticalsAMRX · Health Care | NOK 702.6M | NOK 72.7B | NOK 208.57 | 2.24% down | 79% up | ||
| 20 | Arrowhead PharmaceuticalsARWR · Health Care | -NOK 15.9M | NOK 60.2B | NOK 425.61 | 1.25% up | 8% up | ||
| 21 | Mirum PharmaceuticalsMIRM · Health Care | -NOK 227.8M | NOK 60.8B | NOK 931.28 | 3.27% up | 35% up | ||
| 22 | Travere TherapeuticsTVTX · Health Care | -NOK 249.1M | NOK 45.2B | NOK 470.95 | 3.86% down | 39% up | ||
| 23 | VeradermicsMANE · Health Care | -NOK 682.5M | NOK 51.2B | NOK 1,212.88 | 0.38% down | 230% up | ||
| 24 | Belite BioBLTE · Health Care | -NOK 756.8M | NOK 59.8B | NOK 1,472.54 | 3.33% down | 25% up | ||
| 25 | Oruka TherapeuticsORKA · Health Care | -NOK 1B | NOK 64.5B | NOK 951.37 | 1.91% up | 233% up | ||
| 26 | ErascaERAS · Health Care | -NOK 1.2B | NOK 48.7B | NOK 138.65 | 3.34% up | 387% up | ||
| 27 | Protagonist TherapeuticsPTGX · Health Care | -NOK 1.3B | NOK 78.9B | NOK 1,209.27 | 2.47% down | 45% up | ||
| 28 | Spyre TherapeuticsSYRE · Health Care | -NOK 1.5B | NOK 90.4B | NOK 951.95 | 3.77% down | 302% up | ||
| 29 | Dianthus TherapeuticsDNTH · Health Care | -NOK 1.6B | NOK 46.6B | NOK 827.15 | 1.01% up | 105% up | ||
| 30 | Edgewise TherapeuticsEWTX · Health Care | -NOK 1.6B | NOK 43.9B | NOK 401.43 | 0.48% down | 82% up | ||
| 31 | Axsome TherapeuticsAXSM · Health Care | -NOK 1.8B | NOK 69.6B | NOK 1,322.96 | 1.25% up | 9% down | ||
| 32 | Definium TherapeuticsDFTX · Health Care | -NOK 1.8B | NOK 39.4B | NOK 287.45 | 1.24% up | 176% up | ||
| 33 | Rhythm PharmaceuticalsRYTM · Health Care | -NOK 1.9B | NOK 79B | NOK 1,138.87 | 1.88% down | 15% up | ||
| 34 | Elanco Animal HealthELAN · Health Care | -NOK 2.3B | NOK 128.1B | NOK 256.34 | 1.54% down | 18% up | ||
| 35 | Madrigal PharmaceuticalsMDGL · Health Care | -NOK 2.8B | NOK 89.9B | NOK 3,868.46 | 0.34% down | 28% down | ||
| 36 | Legend BiotechLEGN · Health Care | -NOK 2.9B | NOK 30.5B | NOK 156.98 | 0.92% down | 43% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | -NOK 3B | NOK 84.7B | NOK 3,031.47 | 1.87% up | 83% up | ||
| 38 | Cogent BiosciencesCOGT · Health Care | -NOK 3.2B | NOK 47.1B | NOK 270.48 | 0.25% down | 25% down | ||
| 39 | Ionis PharmaceuticalsIONS · Health Care | -NOK 3.7B | NOK 44.2B | NOK 265.41 | 0.62% down | 64% down | ||
| 40 | BridgeBio PharmaBBIO · Health Care | -NOK 7.1B | NOK 148.5B | NOK 762.30 | 0.22% up | 15% up | ||
| 41 | CytokineticsCYTK · Health Care | -NOK 7.7B | NOK 69.9B | NOK 501.77 | 0.27% up | 21% down | ||
| 42 | Summit TherapeuticsSMMT · Health Care | -NOK 10.5B | NOK 82.4B | NOK 103.06 | 0.67% up | 35% down | ||
| 43 | InsmedINSM · Health Care | -NOK 12.4B | NOK 309B | NOK 1,408.57 | 20.58% up | 27% down | ||
| 44 | ViatrisVTRS · Health Care | -NOK 34.3B | NOK 222.2B | NOK 193.84 | 1.97% down | 90% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7506 NOK).
Questions and answers
Which pharmaceutical companies in the United States rank first by earnings?
Johnson & Johnson (NOK 261.4B), Eli Lilly (NOK 201.3B) and Merck & Co (NOK 178B) are the top three of the 44 pharmaceutical companies in the United States ranked by earnings as of 20 Nov 2026, 13:40 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by earnings.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by earnings have a combined market value of NOK 36.43T as of 20 Nov 2026, 13:40 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by earnings”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.